EDITAS MEDICINE, INC. (EDIT)

Import this data to Google Sheets with:

=jivedata("EDIT","financials")

Full statements spill as a table. For one cell: =jivedata("EDIT","Revenue") or =jivedata("EDIT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

EDITAS MEDICINE, INC.

EDIT • CIK 0001650664

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$78,123	$32,314	$40,520	$47,005
Operating Income (Loss)	$-169,181	$-251,152	$-160,010	$-75,860
Net Income (Loss) Attributable to Parent	$-153,219	$-237,093	$-160,060	$-73,949
Weighted Average Number of Shares Outstanding, Basic	75,965,633	82,338,220	88,745,908	113,654,663
Research and Development Expense	$177,651	$199,247	$89,953	$84,959
General and Administrative Expense	$69,653	$71,987	$49,903	$45,506
Restructuring, Settlement and Impairment Provisions	—	—	$60,674	$-7,600
Operating Expenses	$247,304	$283,466	$200,530	$122,865
Interest Expense, Debt	—	$2,128	$6,171	$4,068
Investment Income, Net	$17,566	$14,062	$8,310	$6,081
Other Nonoperating Income (Expense)	$-1,604	$-3	$-2,189	$-102
Nonoperating Income (Expense)	$15,962	$14,059	$-50	$1,911

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$123,652	$131,541	$146,645	$181,815
Marketable Securities, Current	$199,459	$138,372	$0	$29,830
Property, Plant and Equipment, Net	$12,032	$14,497	$3,542	$2,574
Receivables, Net, Current	$10,187	$16,266	$15,176	$2,725
Operating Lease, Right-of-Use Asset	$33,680	$32,554	$16,121	$13,747
Prepaid Expense and Other Assets, Current	$7,531	$3,136	$2,074	$3,697
Other Assets, Noncurrent	$8,588	$5,223	$2,976	$2,976
Assets, Current	$340,829	$289,315	$163,895	$218,067
Assets	$499,153	$341,589	$186,534	$237,364
Operating Lease, Liability, Noncurrent	$24,372	$20,380	$12,071	$8,998
Long-term Debt, Excluding Current Maturities	—	$52,434	$53,605	$48,238
Contract with Customer, Liability, Noncurrent	$60,667	$54,204	$44,509	$4,000
Other Liabilities, Noncurrent	$1,800	$3,072	$2,815	$2,413
Liabilities	$150,056	$207,315	$159,246	$132,083
Accounts Payable, Current	$8,269	$5,493	$2,605	$4,741
Accrued Liabilities, Current	$34,563	$45,859	$32,610	$17,365
Long-term Debt, Current Maturities	—	$5,000	$5,000	$7,500
Contract with Customer, Liability, Current	$8,221	$6,221	$0	$32,315
Operating Lease, Liability, Current	$12,164	$14,652	$6,031	$6,513
Liabilities, Current	$63,217	$77,225	$46,246	$68,434
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$8	$8	$10	$15
Additional Paid in Capital, Common Stock	$1,580,241	$1,602,441	$1,655,781	$1,776,987
Accumulated Other Comprehensive Income (Loss), Net of Tax	$198	$268	$0	$-6
Retained Earnings (Accumulated Deficit)	$-1,231,350	$-1,468,443	$-1,628,503	$-1,671,715
Stockholders' Equity Attributable to Parent	$349,097	$134,274	$27,288	$105,281
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	195,000,000	195,000,000	390,000,000	390,000,000
Common Stock, Shares, Issued	81,767,263	82,734,696	97,866,996	153,530,898

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-153,219	$-237,093	$-160,060	$-73,949
Net Cash Provided by (Used in) Operating Activities	$-132,178	$-210,284	$-165,241	$-119,859
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-17,870	$7,889	$13,897	$42,066
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$127,529	$135,418	$149,315	$133,064
Share-based Payment Arrangement, Noncash Expense	$19,798	$21,417	$10,000	$8,652
Payments to Acquire Property, Plant, and Equipment	$4,719	$8,826	$607	$691
Depreciation	$6,064	$5,809	$5,277	$2,425
Proceeds from Sale of Machinery and Equipment	$0	$0	$269	$274
Gain (Loss) on Disposition of Property Plant Equipment	—	$-149	$-2,193	$-111
Payments to Acquire Marketable Securities	$258,517	$86,217	$0	$29,694
Investment Income, Net, Amortization of Discount and Premium	$4,823	$5,791	$902	$204
Proceeds from Sale and Maturity of Marketable Securities	$259,505	$257,189	$139,006	$40,006
Net Cash Provided by (Used in) Investing Activities	$-3,731	$162,146	$138,668	$9,895
Impairment of Long-Lived Assets to be Disposed of	—	—	$3,758	$34
Other Noncash Income (Expense)	$-1,596	$415	$449	$76
Repayments of Debt	—	—	$2,872	$0
Proceeds from Issuance of Common Stock	$117,079	$0	$42,848	$151,728
Proceeds from Stock Options Exercised	$41	$193	$70	$106
Proceeds from Stock Plans	$919	$590	$424	$196
Net Cash Provided by (Used in) Financing Activities	$118,039	$56,027	$40,470	$152,030
Cash and Cash Equivalents, at Carrying Value	$123,652	$131,541	$146,645	$131,601
Restricted Cash	—	$3,877	$2,670	$1,463
Capital Expenditures Incurred but Not yet Paid	$845	$65	$0	$0
Operating Lease, Payments	$12,428	$18,447	$14,968	$7,931
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$2,752	$794	$766	$793
InterestExpenseNonoperating	—	—	$2,128	$5,000
Stock Issued	—	$1,479	$0	$0
Increase (Decrease) in Accounts Receivable	$5,042	$6,079	$-1,090	$2,137
Increase (Decrease) in Prepaid Expense and Other Assets	$197	$-4,396	$-1,062	$143
Increase (Decrease) in Other Noncurrent Assets	$3,335	$-3,366	$-1,040	$-15
Increase (Decrease) in Accounts Payable	$-1,492	$-2,286	$-2,888	$-2,450
Increase (Decrease) in Accrued Liabilities	$4,114	$11,623	$-13,184	$-30,852
Increase (Decrease) in Contract with Customer, Liability	$0	$-8,463	$-15,916	$-17,889
IncreaseDecreaseInOperatingLeaseLiability	$-7,410	$-1,504	$-12,081	$-5,475
Increase (Decrease) in Other Noncurrent Liabilities	—	—	$192	$-2,121

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("EDIT","financials")

Full statements spill as a table. For one cell: =jivedata("EDIT","Revenue") or =jivedata("EDIT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.